keyword
https://read.qxmd.com/read/38713328/purinergic-regulation-of-pulmonary-vascular-tone
#1
REVIEW
Marco Alveal, Andrea Méndez, Aline García, Mauricio Henríquez
Purinergic signaling is a crucial determinant in the regulation of pulmonary vascular physiology and presents a promising avenue for addressing lung diseases. This intricate signaling system encompasses two primary receptor classes: P1 and P2 receptors. P1 receptors selectively bind adenosine, while P2 receptors exhibit an affinity for ATP, ADP, UTP, and UDP. Functionally, P1 receptors are associated with vasodilation, while P2 receptors mediate vasoconstriction, particularly in basally relaxed vessels, through modulation of intracellular Ca2+ levels...
May 7, 2024: Purinergic Signalling
https://read.qxmd.com/read/38713049/-on-the-formation-of-russian-pulmonology-the-development-of-the-doctrine-of-lung-diseases-first-half-of-the-20th-century
#2
JOURNAL ARTICLE
V I Borodulin, E N Banzelyuk, A V Topolyanskiy
The articles on the history of Russian pulmonology presented in the historical, medical and therapeutic literature contain materials for this history, but their authors did not solve the problem of its consistent presentation, highlighting the stages of formation and founders. The authors of this study critically reviewed the literary and archival primary sources, for the first time proposed the identification of three stages in the development of Russian pulmonology and indicated eight of its founders at these stages...
April 16, 2024: Terapevticheskiĭ Arkhiv
https://read.qxmd.com/read/38713047/-pulmonary-fibrosis-after-a-new-coronavirus-infection-versions-and-controversies-a-review
#3
REVIEW
E I Shchepikhin, E I Shmelev, A E Ergeshov
Fibrosis is a dynamic process characterized by a typical cascade of events as a result of overexpressed repair of connective tissue in response to injury, and manifested by excessive accumulation of extracellular matrix. The development of fibrosis is a determining factor in the pathogenesis, clinical course and prognosis of many diseases, among which interstitial lung diseases occupy a special place. According to a large Russian registry (ClinicalTrials.gov: NCT04492384), in a third of patients with COVID-19, the volume of lung parenchyma involvement exceeds 50% (CT 3-4)...
April 16, 2024: Terapevticheskiĭ Arkhiv
https://read.qxmd.com/read/38713046/-new-clinical-guidelines-for-copd-a-paradigm-shift-a-review
#4
REVIEW
S N Avdeev, I V Leshchenko, Z R Aisanov, V V Arkhipov, A S Belevskiy, S I Ovcharenko, A V Emelyanov, A I Sinopalnikov, E I Shmelev, A G Chuchalin
Chronic obstructive pulmonary disease is now one of the most common noncommunicable diseases and the main causes of morbidity, disability and mortality in the world. In recent years, new approaches to epidemiology, diagnosis, classification (categorization), evaluation of phenotypes, as well as characterization and assessment of the severity of сhronic obstructive pulmonary disease exacerbations have emerged. Modern approaches to starting and subsequent drug therapy have changed significantly. This is largely due to the results of recently conducted major clinical trials, demonstrated high efficacy of triple fixed combinations, including inhaled glucocorticosteroids, long-acting beta-agonists and long-acting anticholinergic drugs...
April 16, 2024: Terapevticheskiĭ Arkhiv
https://read.qxmd.com/read/38712717/migration-of-etonogestrel-subcutaneous-contraceptive-implants-systematic-review-and-recommendations-for-practice
#5
REVIEW
Édith Guilbert, Hélène Arguin, Mathieu Bélanger
INTRODUCTION: Migration is a rare but serious complication of the etonogestrel contraceptive implant, and little is known about its extent. PURPOSE: To document and characterise cases of etonogestrel contraceptive implant migration in the scientific literature. METHODS: A systematic review of Medline, Embase and Global Health databases was carried out between January 2000 and January 2023 to identify articles presenting implant migrations...
May 7, 2024: European Journal of Contraception & Reproductive Health Care
https://read.qxmd.com/read/38711393/can-we-define-difficult-to-treat-systemic-sclerosis
#6
REVIEW
Gabriella Szűcs, Szilvia Szamosi, Zoltán Szekanecz
INTRODUCTION: Systemic sclerosis (SSc) is a chronic autoimmune rheumatic disease characterized by microvascular alterations, immunopathology and widespread fibrosis involving various organs. It is considered difficult to treat due to several reasons: complex pathogenesis, heterogeneity, late diagnosis, limited treatment options for certain organ manifestations, lack of personalized medicine. AREAS COVERED: This review presents the heterogeneity, survival and organ manifestations with their risk factors of systemic sclerosis and their current treatment options, while drawing attention to difficult-to-treat forms of the disease, based on literature indexed in PubMed...
May 7, 2024: Expert Review of Clinical Immunology
https://read.qxmd.com/read/38711031/harmonization-of-clinical-practice-guidelines-for-primary-prevention-and-screening-actionable-recommendations-and-resources-for-primary-care
#7
REVIEW
Carolina Fernandes, Denise Campbell-Scherer, Aisha Lofters, Eva Grunfeld, Kris Aubrey-Bassler, Heidi Cheung, Katherine Latko, Wendy Tink, Richard Lewanczuk, Melissa Shea-Budgell, Ruth Heisey, Tracy Wong, Huiming Yang, Sakina Walji, Margo Wilson, Elizabeth Holmes, Kelly Lang-Robertson, Christina DeLonghi, Donna Patricia Manca
BACKGROUND: Clinical practice guidelines (CPGs) synthesize high-quality information to support evidence-based clinical practice. In primary care, numerous CPGs must be integrated to address the needs of patients with multiple risks and conditions. The BETTER program aims to improve prevention and screening for cancer and chronic disease in primary care by synthesizing CPGs into integrated, actionable recommendations. We describe the process used to harmonize high-quality cancer and chronic disease prevention and screening (CCDPS) CPGs to update the BETTER program...
May 6, 2024: BMC Prim Care
https://read.qxmd.com/read/38710878/a-systematic-review-and-meta-analysis-of-the-morbidity-of-efficacy-endpoints-and-bleeding-events-in-elderly-and-young-patients-treated-with-the-same-dose-rivaroxaban
#8
REVIEW
Jianwei Ren, Na Wang, Xuan Zhang, Fuyu Song, Xin Zheng, Xiaohong Han
Rivaroxaban is a new direct oral anticoagulant, and the same dose is recommended for older and young patients. However, recent real-world studies show that older patients may need dose adjustment to prevent major bleeding. At present, the evidence for dose adjustment in older patients is extremely limited with only a few reports on older atrial fibrillation patients. The aim of this study was to review the morbidity data of adverse events and bleeding events across all indications for older and young patients treated with the same dose of rivaroxaban to provide some support for dosage adjustment in older patients...
May 7, 2024: Annals of Hematology
https://read.qxmd.com/read/38710468/arachidonic-acid-in-aging-new-roles-for-old-players
#9
REVIEW
Chen Qian, Qing Wang, Yusen Qiao, Ze Xu, Linlin Zhang, Haixiang Xiao, Zhixiang Lin, Mingzhou Wu, Wenyu Xia, Huilin Yang, Jiaxiang Bai, Dechun Geng
BACKGROUND: Arachidonic acid (AA), one of the most ubiquitous polyunsaturated fatty acids (PUFAs), provides fluidity to mammalian cell membranes. It is derived from linoleic acid (LA) and can be transformed into various bioactive metabolites, including prostaglandins (PGs), thromboxanes (TXs), lipoxins (LXs), hydroxy-eicosatetraenoic acids (HETEs), leukotrienes (LTs), and epoxyeicosatrienoic acids (EETs), by different pathways. All these processes are involved in AA metabolism. Currently, in the context of an increasingly visible aging world population, several scholars have revealed the essential role of AA metabolism in osteoporosis, chronic obstructive pulmonary disease, and many other aging diseases...
May 4, 2024: Journal of Advanced Research
https://read.qxmd.com/read/38710372/disease-progression-modeling-with-temporal-realignment-an-emerging-approach-to-deepen-knowledge-on-chronic-diseases
#10
REVIEW
Hideki Yoshioka, Ryota Jin, Akihiro Hisaka, Hiroshi Suzuki
The recent development of the first disease-modifying drug for Alzheimer's disease represents a major advancement in dementia treatment. Behind this breakthrough is a quarter century of research efforts to understand the disease not by a particular symptom at a given moment, but by long-term sequential changes in multiple biomarkers. Disease progression modeling with temporal realignment (DPM-TR) is an emerging computational approach proposed with this biomarker-based disease concept. By integrating short-term clinical observations of multiple disease biomarkers in a data-driven manner, DPM-TR provides a way to understand the progression of chronic diseases over decades and predict individual disease stages more accurately...
May 4, 2024: Pharmacology & Therapeutics
https://read.qxmd.com/read/38710221/review-of-pulmonary-manifestations-in-antisynthetase-syndrome
#11
JOURNAL ARTICLE
Mohammad I Ghanbar, Sonye K Danoff
Antisynthetase syndrome (ASyS) is now a widely recognized entity within the spectrum of idiopathic inflammatory myopathies. Initially described in patients with a triad of myositis, arthritis, and interstitial lung disease (ILD), its presentation can be diverse. Additional common symptoms experienced by patients with ASyS include Raynaud's phenomenon, mechanic's hand, and fever. Although there is a significant overlap with polymyositis and dermatomyositis, the key distinction lies in the presence of antisynthetase antibodies (ASAs)...
May 6, 2024: Seminars in Respiratory and Critical Care Medicine
https://read.qxmd.com/read/38709946/breath-hold-diving-injuries-a-primer-for-medical-providers
#12
REVIEW
Elaine Yu, Juan M Valdivia-Valdivia, Fernando Silva, Peter Lindholm
Breath-hold divers, also known as freedivers, are at risk of specific injuries that are unique from those of surface swimmers and compressed air divers. Using peer-reviewed scientific research and expert opinion, we created a guide for medical providers managing breath-hold diving injuries in the field. Hypoxia induced by prolonged apnea and increased oxygen uptake can result in an impaired mental state that can manifest as involuntary movements or full loss of consciousness. Negative pressure barotrauma secondary to airspace collapse can lead to edema and/or hemorrhage...
May 1, 2024: Current Sports Medicine Reports
https://read.qxmd.com/read/38708464/evaluation-of-airway-responsiveness-and-pulmonary-function-test-results-among-obese-and-non-obese-patients-with-obstructive-sleep-apnea-syndrome
#13
JOURNAL ARTICLE
S Ayik, A Dalli, M K Sözmen, G Akhan
OBJECTIVE: In this research, we aimed to elucidate the effect of obstructive sleep apnea syndrome (OSAS) and obesity on pulmonary volumes and bronchial hyperreactivity, and particularly the effect of supine position on pulmonary volume and functions. PATIENTS AND METHODS: This was a prospective, cross-sectional study with a total of 96 patients (age range, 20-65 years). Based on the body mass index (BMI) and Apnea-Hypopnea Index (AHI) scores, the patients were divided into four groups: Group 1: AHI≥15/h, BMI≥30 kg/m2 (n=24), Group 2: AHI≥15/h, BMI<30 kg/m2 (n=24), Group 3: AHI<15/h, BMI≥30 kg/m2 (n=24), and Group 4: AHI<15/h, BMI<30 kg/m2 (n=24)...
April 2024: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/38708410/race-adjustment-of-pulmonary-function-tests-in-the-diagnosis-and-management-of-copd-a-scoping-review
#14
REVIEW
Sean Richard Davidson, Muhammed Y Idris, Christopher S Awad, Marshaleen Henriques King, Gloria E Westney, Mario Ponce, Anny D Rodriguez, Kim L Lipsey, Eric L Flenaugh, Marilyn G Foreman
AIM: Increasing evidence suggests that the inclusion of self-identified race in clinical decision algorithms may perpetuate longstanding inequities. Until recently, most pulmonary function tests utilized separate reference equations that are race/ethnicity based. PURPOSE: We assess the magnitude and scope of the available literature on the negative impact of race-based pulmonary function prediction equations on relevant outcomes in African Americans with COPD. METHODS: We performed a scoping review utilizing an English language search on PubMed/Medline, Embase, Scopus, and Web of Science in September 2022 and updated it in December 2023...
2024: International Journal of Chronic Obstructive Pulmonary Disease
https://read.qxmd.com/read/38708038/is-there-a-role-for-lung-or-bronchial-biopsies-for-the-diagnosis-of-mycobacterial-pulmonary-disease-in-patients-with-bronchiectasis
#15
JOURNAL ARTICLE
Rottem Kuint, Avraham Abutbul, Zvi G Fridlender, Uri Laxer, Neville Berkman
BACKGROUND: Workup of bronchiectasis patients mandates microbiological characterization often being sought via Bronchoscopy. However, whether to perform bronchial or lung biopsies, is unknown, especially for the diagnosis of NTM pulmonary disease. We aimed to assess the current practice and yield of the different bronchoscopic procedures in this setting. METHODS: Data from an adult cohort with bronchiectasis referred for bronchoscopy for microbiologic sampling was reviewed, including demographics, etiology, imaging and results of the different bronchoscopic procedures performed...
August 2024: Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
https://read.qxmd.com/read/38707946/hypertensive-emergency-team-based-learning
#16
JOURNAL ARTICLE
Khoa Nguyen, Jordan Gawon Shin, Jessica Andrusaitis
AUDIENCE: The target audiences for this team-based learning (TBL) activity are resident physicians and medical students. INTRODUCTION: According to the Centers for Disease Control and Prevention (CDC), nearly half of the adults in the United States have hypertension,1 which is a leading cause of cardiovascular disease and premature death.2 In extreme cases, patients may present in hypertensive emergencies, defined as an acute, marked elevation of systolic blood pressure >180mmHg or diastolic blood pressure >120mmHg with evidence of organ dysfunction...
April 2024: Journal of education & teaching in emergency medicine
https://read.qxmd.com/read/38707895/antiphospholipid-antibody-related-hepatic-vasculitis-in-a-juvenile-after-non-severe-covid-19-a-case-report-and-literature-review
#17
REVIEW
Qingyu Li, Jingya Li, Menglan Zhou, Ying Ge, Zhengyin Liu, Taisheng Li, Li Zhang
Antiphospholipid antibodies (aPL) are both laboratory evidence and causative factors for a broad spectrum of clinical manifestations of antiphospholipid syndrome (APS), with thrombotic and obstetric events being the most prevalent. Despite the aPL-triggered vasculopathy nature of APS, vasculitic-like manifestations rarely exist in APS and mainly appear associated with other concurrent connective tissue diseases like systemic lupus erythematous. Several studies have characterized pulmonary capillaritis related to pathogenic aPL, suggesting vasculitis as a potential associated non-thrombotic manifestation...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38707719/short-course-radiotherapy-for-airway-stenting-in-malignant-airway-obstruction-a-case-report-and-literature-review
#18
JOURNAL ARTICLE
Giuseppe Facondo, Chiara Reverberi, Tino Ceschia, Giuseppe Parisi, Gianluca Vullo, Eugenia Moretti, Marco Trovò
BACKGROUND: Malignant airway obstruction (MAO) secondary to tumor growth occurs in nearly a third of patients with lung cancer and portends a very poor prognosis if untreated. Treatment options include bronchoscopic intervention with tumor debulking, stent placement, endobronchial brachytherapy, or palliative radiotherapy. CASE REPORT: This is a report of a 74-year-old woman with a medical history of metastatic lung adenocarcinoma, hospitalized for dyspnea, hemoptysis, and chest pain with a radiographic finding of MAO on chest X-ray and computed tomography...
2024: Cancer Diagn Progn
https://read.qxmd.com/read/38707160/revolutionizing-pulmonary-diagnostics-a-narrative-review-of-artificial-intelligence-applications-in-lung-imaging
#19
REVIEW
Arman Sindhu, Ulhas Jadhav, Babaji Ghewade, Jay Bhanushali, Pallavi Yadav
Artificial intelligence (AI) has emerged as a transformative force in healthcare, particularly in pulmonary diagnostics. This comprehensive review explores the impact of AI on revolutionizing lung imaging, focusing on its applications in detecting abnormalities, diagnosing pulmonary conditions, and predicting disease prognosis. We provide an overview of traditional pulmonary diagnostic methods and highlight the importance of accurate and efficient lung imaging for early intervention and improved patient outcomes...
April 2024: Curēus
https://read.qxmd.com/read/38707018/covid-19-and-its-sequelae-masquerading-as-gastrointestinal-ailments-a-report-of-gastroesophageal-reflux-disease-gerd-and-review-of-recent-cases
#20
Faris Shweikeh, Gordon Hong, Sana Rabeeah, Usma Shabir, Aijaz Sofi
Coronavirus disease 2019 (COVID-19) predominantly causes respiratory symptoms. However, a rare segment of patients recovering from COVID-19 may develop gastrointestinal (GI) symptoms. We describe a case of a female who presented with symptoms suggestive of refractory gastroesophageal reflux disease (GERD) for 18 months following COVID-19 infection. Her symptoms included epigastric and chest pain, coughing, and vomiting. Upper endoscopy and 24-hour pH monitoring were negative. Following hospital admission due to worsening symptoms, she was diagnosed with chronic pulmonary embolism (PE) presumed to be related to COVID-19...
April 2024: Curēus
keyword
keyword
63696
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.